Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin vs Amphotericin B in High Risk Hepatic Transplant Recipients
NCT01303549Phase 4Completed
- Sponsor
- Fundación SEIMC-GeSIDA
- Start
- Nov 2011
- Primary completion
- May 2014
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of anidulafungin in invasive fungal infection (IFI), sponsored by Fundación SEIMC-GeSIDA. Started Nov 2011; status: completed.
02
Drugs
anidulafungin
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT01303549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303549.